Basal damage and oxidative DNA damage in children with chronic kidney disease measured by use of the comet assay

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 725, Issue 1-2, 2011, Pages 22-28

  Aykanat, Banu ^a   Demircigil, Gonca Cakmak ^a   Fidan, Kibriya ^a   Buyan, Necla ^a   Gulleroglu, Kaan ^b   Baskin, Esra ^b   Bayrakci, Umut Selda ^b   Sepici, Aylin ^a   Buyukkaragoz, Bahar ^a   Karakayali, Hamdi ^b   Haberal, Mehmet ^b   Burgaz, Sema ^a  

^a GAZI UNIVERSITY   (Turkey)

^b BASKENT UNIVERSITY   (Turkey)

Author keywords

Basal DNA damage; Children; Chronic kidney disease; Comet assay; Oxidative DNA damage

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIHYPERTENSIVE AGENT; CALCIUM ACETATE; CITRATE CALCIUM; CITRATE SODIUM; CITRIC ACID; CYCLOSPORIN; DNA; DNA FORMAMIDOPYRIMIDINE GLYCOSYLASE; ENDONUCLEASE; ERYTHROPOIETIN; IRON; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID; TACROLIMUS;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ANTIHYPERTENSIVE THERAPY; ARTICLE; BASAL DNA DAMAGE; CHILD; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; COMET ASSAY; CONTROLLED STUDY; DIALYSIS; DNA DAMAGE; ENZYME MODIFIED COMET ASSAY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY GRAFT; MALE; OXIDATIVE DNA DAMAGE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SCHOOL CHILD; VITAMIN SUPPLEMENTATION;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHRONIC DISEASE; COMET ASSAY; DNA DAMAGE; FEMALE; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; OXIDATIVE STRESS; RENAL DIALYSIS;

EID: 80052401632     PISSN: 13835718     EISSN: 18793592     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2011.07.005     Document Type: Article

References (54)

1. Clark L.E., Khan I. Outcomes in CKD: what we know and what we need to know. Nephron Clin. Pract. 2010, 114(2):c95-c102.
2. Wall B.M. Cardiorenal risk factors. Am. J. Med. Sci. 2010, 340(1):25-29.
3. Rodriguez-Iturbe B., Correa-Rotter R. Cardiovascular risk factors and prevention of cardiovascular disease in patients with chronic renal disease. Expert Opin. Pharmacother. 2010, 11(16):2687-2698.
4. Fabrizi F., Messa P., Basile C., Martin P. Hepatic disorders in chronic kidney disease. Nat. Rev. Nephrol. 2010, 6(7):395-403.
5. Goldfarb-Rumyantzev A.S., Rout P. Characteristics of elderly patients with diabetes and end-stage renal disease. Semin. Dial. 2010, 23(2):185-190.
6. Krishnan A.V., Pussell B.A., Kiernan M.C. Neuromuscular disease in the dialysis patient: an update for the nephrologist. Semin. Dial. 2009, 22(3):267-278.
7. Agraharkar M.L., Cinclair R.D., Kou Y.F., Daller J.A., Shahinian V.B. Risk of malignancy with long-term immunosuppression in renal transplant recipients. Kidney Int. 2004, 66:383-389.
8. Ribeiro D.A., Campos R.R., Bergamaschi C.T. Chronic renal failure induces genetic instability in multiple organs of Wistar rats. Eur. J. Clin. Invest. 2009, 39(4):289-295.
9. Hirotsu C., Tufik S., Ribeiro D.A., Alvarenga T.A., Andersen M.L. Genomic damage in the progression of chronic kidney disease in rats. Brain Behav. Immun. 2011, 25(3):416-422.
10. Maisonneuve P., Agodoa L., Gellert R., Stewart J.H., Buccianti G., Lowenfels A.B., Wolfe R.A., Jones E., Disney A.P., Briggs D., McCredie M., Boyle P. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 1999, 354:93-98.
11. Kao M.P., Ang D.S., Pall A., Struthers A.D. Oxidative stress in renal dysfunction: mechanisms, clinical sequelae and therapeutic options. J. Hum. Hypertens. 2010, 24(1):1-8.
12. Filiopoulos V., Hadjiyannakos D., Takouli L., Metaxaki P., Sideris V., Vlassopoulos D. Inflammation and oxidative stress in end-stage renal disease patients treated with hemodialysis or peritoneal dialysis. Int. J. Artif. Organs 2009, 32(12):872-882.
13. Schupp N., Schinzel R., Heidland A., Stopper H. Genotoxicity of advanced glycation end products: involvement of oxidative stress and of angiotensin II type 1 receptors. Ann. N.Y. Acad. Sci. 2005, 1043:685-695.
14. Roth J.M., Restani R.G., Gonçalves T.T.S., Sphor S.L.S., Ness A.B., Martino-Roth M.G., Garcias G.L. Genotoxicity evaluation in chronic renal patients undergoing hemodialysis and peritoneal dialysis, using the micronucleus test. Genet. Mol. Res. 2008, 7(2):433-443.
15. Rao S.N. Cancer screening in end-stage renal disease. Saudi J. Kidney Dis. Transpl. 2009, 20(5):737-740.
16. Andreoli S.P., Brewer E.D., Watkins S., Fivush B B., Powe N., Shevchek J., Foreman J. American society of pediatric nephrology position paper on linking reimbursement to quality of care. J. Am. Soc. Nephrol. 2005, 16:2263-2269.
17. Coutinho H.M., Groothoff J.W., Offringa M., Gruppen M.P., Heymans H.S.A. De novo malignancy after paediatric renal replacement therapy. Arch. Dis. Child. 2001, 85:478-483.
18. Buyan N., Türkmen M.A., Bilge I., Baskin E., Haberal M., Bilginer Y., Mir S., Emre S., Akman S., Ozkaya O., Fidan K., Alpay H., Kavukcu S., Sever L., Ozçakar Z.B., Dogrucan N. Quality of life in children with chronic kidney disease (with child and parent assessments). Pediatr. Nephrol. 2010, 25(8):1487-1496.
19. Antolini F., Valente F., Ricciardi D., Baroni M. Principal component analysis of some oxidative stress parameters and their relationships in hemodialytic and transplanted patients. Clin. Chim. Acta 2005, 358(1-2):87-94.
20. Stopper H H., Boullay F., Heidland A., Vienken J. Comet-assay analysis identifies genomics damage in lymphocytes of uremic patients. Am. J. Kidney Dis. 2001, 38:296-301.
21. Giray B., Kan E., Bali M., Hincal F. The effect of vitamin E supplementation on antioxidant enzyme activities and lipid peroxidation levels in hemodialysis patients. Clin. Chim. Acta 2003, 338(1-2):91-98.
22. Tarng D.-C., Tsai T.-J., Chen W.-T., Liu T.-Y. Effect of human OGG1 1245C→G gene polymorphism on 8-hydroxy-2-deoxyguanosine levels of leukocyte DNA among patients undergoing chronic hemodialysis. J. Am. Soc. Nephrol. 2001, 12:2338-2347.
23. Kobras K., Schupp N., Nehrlich K., Adelhardt M. Relation between different treatment modalities and genomic damage of end-stage renal failure patients. Kidney Blood Press. Res. 2006, 29:10-17.
24. Buemi M., Floccari F., Costa C., Caccamo C. Dialysis-related genotoxicity: sister chromatid exchanges and DNA lesions in T and B lymphocytes of uremic patients. Genomic damage in patients on hemodiafiltration. Blood Purif. 2006, 24:569-574.
25. Kan E., Undeĝer U., Bali M., Başaran N. Assessment of DNA strand breakage by the alkaline COMET assay in dialysis patients and the role of vitamin E supplementation. Mutat. Res. 2002, 26(520(1-2)):151-159.
26. Horoz M., Bolukbas C., Bolukbas F.F., Aslan M. Oxidative stress in hepatitis C infected end-stage renal disease subjects. BMC Infect. Dis. 2006, 6:114.
27. Stoyanova E., Sandoval S.B., Zuniga L.A., El-Yamani N., Coll E., Pastor S., Reyes J., Andrés E., Ballarin J., Xamena N., Marcos R. Oxidative DNA damage in chronic renal failure patients. Nephrol. Dial. Transplant. 2010, 25(3):879-885.
28. Domenici F.A., Vannucchi M.T., Jordão A.A., Meirelles M.S., Vannucchi H. DNA oxidative damage in patients with dialysis treatment. Ren. Fail. 2005, 27(6):689-694.
29. Müller C., Eisenbrand G., Gradinger M., Rath T., Albert F.W., Vienken J., Singh R., Farmer P.B., Stockis J.P., Janzowski C. Effects of hemodialysis, dialyser type and iron infusion on oxidative stress in uremic patients. Free Radical Res. 2004, 38(10):1093-1100.
30. Stopper H., Treutlein A.T., Bahner U., Schupp N., Schmid U., Brink A., Perna A., Heidland A. Reduction of the genomic damage level in haemodialysis patients by folic acid and vitamin B12 supplementation. Nephrol. Dial. Transplant. 2008, 23(10):1-8.
31. Stopper H., Meysen T., Böckenförde A., Bahner U., Heidland A., Vamvakas S. Increased genomic damage in lymphocytes of patients before and after long-term maintenance hemodialysis therapy. Am. J. Kidney Dis. 1999, 34(3):433-437.
32. Fragedaki E., Nebel M., Schupp N., Sebekova K., Vökel W., Klassen A., Pischetsrieder M., Frischmann M., Niwa T., Vienken J., Heidland A., Stopper H. Genomic damage and circulating AGE levels in patients undergoing daily versus standart haemodialysis. Nephrol. Dial. Transplant. 2005, 20:1936-1943.
33. Sandoval S.B., Stoyanova E., Coll E., Pastor S., Reyes J., Andrés E., Ballarin J., Xamena N., Marcos R. Genetic damage in chronic renal failure patients is associated with the glomerular filtration rate index. Mutagenesis 2010, 25(6):603-608.
34. Oliveira V.D., Zanki H., Rath T. Mutagenic and cytotoxic effects of immunosuppressive drugs on human lymphocyte cultures. Exp. Clin. Transplant. 2004, 2:273-279.
35. Tice R.R., Agurell E., Anderson D., Burlinson B. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ. Mol. Mutagen. 2000, 35(3):206-221.
36. Speit G., Schütz P., Bonzheim I., Trenz K., Hoffmann H. Sensitivity of the FPG protein towards alkylation damage in the comet assay. Toxicol. Lett. 2004, 146(2):151-158.
37. Demircigil G.C., Aykanat B., Fidan K., Gulleroglu K., Bayrakci U.S., Sepici A., Buyukkaragoz B., Karakayali H., Haberal M., Baskin E., Buyan N., Burgaz S. Genotoxicity assessment of children with chronic kidney disease using the micronucleus test and fluorescence in situ hybridization in lymphocytes. Mutagenesis 2011, 10.1093/mutage/ger027.
38. Singh N., McCoy M., Tice R., Schneider E.A. Simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 1988, 175:184-191.
39. Collins A.R., Duthie S.J., Dobson V.L. Direct enzymic detection of endogenous oxidative base damage in human lymphocyte DNA. Carcinogenesis. 1993, 14:1733-1735.
40. Groothoff J. Long-term outcomes of children with end-stage renal disease. Pediatr. Nephrol. 2005, 20(7):849-853.
41. Dusinska M., Collins A.R. The comet assay in human biomonitoring: gene-environment interactions. Mutagenesis 2008, 23(3):191-205.
42. Möller P P., Knudsen L.E., Loft S., Wallin H. The comet assay as a rapid test in biomonitoring occupational exposure to DNA-damaging agents and effect of confounding factors. Cancer Epidemiol. Biomarkers Prev. 2000, 9(10):1005-1015.
43. Möller P. The alkaline comet assay: towards validation in biomonitoring of DNA damaging exposures. Basic Clin. Pharmacol. Toxicol. 2006, 98(4):336-345.
44. Möller P., Möller L., Godschalk R.W., Jones G.D. Assessment and reduction of comet assay variation in relation to DNA damage: studies from the European Comet Assay Validation Group. Mutagenesis 2010, 25(2):109-111.
45. Speit G., Hartmann A. The comet assay: a sensitive genotoxicity test for the detection of DNA damage and repair. Methods Mol. Biol. 2006, 314:275-286.
46. Dusinska M., Dzupinkova Z., Wsolova L., Harrington V., Collins A.R. Possible involvement of XPA in repair of oxidative DNA damage deduced from analysis of damage, repair and genotype in a human population study. Mutagenesis 2006, 21(3):205-211.
47. European Standards Committee on Oxidative and Damage (ESCODD) Measurement of DNA oxidation in human cells by chromatographic and enzymic methods. Free Radical Biol. Med. 2003, 34(8):1089-1099.
48. Smith C.C., O'Donovan M.R., Martin E.A. hOGG1 recognizes oxidative damage using the comet assay with greater specificity than FPG or ENDOIII. Mutagenesis 2006, 21(3):185-190.
49. Bonassi S., El-Zein R., Bolognesi C., Fenech M. Micronuclei frequency in peripheral blood lymphocytes and cancer risk: evidence from human studies. Mutagenesis 2011, 26(1):93-100.
50. Wang X.L., Rainwater D.L., VandeBerg J.F., Mitchell B.D., Mahaney M.C. Genetic contributions to plasma total antioxidant activity. Arterioscler. Thromb. Vasc. Biol. 2001, 21:1190-1195.
51. Cengiz N., Baskin E., Sezgin N., Agras P., Haberal M. Oxidative stress in children on hemodialysis: value of autoantibodies against oxidized low-density lipoprotein. Pediatr. Nephrol. 2009, 24(2):387-393.
52. Simic-Ogrizovic S., Simic T., Reljic Z., Markovic S., Blagojevic R., Radivojevic D., Lezaic V., Djukanovic L., Mimic-Oka J. Markers of oxidative stress after renal transplantation. Transpl. Int. 1998, 11(Suppl. 1):S125-S129.
53. Battershill J.M., Burnett K., Bull S. Factors affecting the incidence of genotoxicity biomarkers in peripheral blood lymphocytes: impact on design of biomonitoring studies. Mutagenesis 2008, 23(6):423-437.
54. Van Heurn E., de Vries E.E. Kidney transplantation and donation in children. Pediatr. Surg. Int. 2009, 25(5):385-393.